Timo Minssen

3.8k total citations
128 papers, 1.4k citations indexed

About

Timo Minssen is a scholar working on Public Health, Environmental and Occupational Health, Physiology and Management of Technology and Innovation. According to data from OpenAlex, Timo Minssen has authored 128 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Public Health, Environmental and Occupational Health, 33 papers in Physiology and 29 papers in Management of Technology and Innovation. Recurrent topics in Timo Minssen's work include Biomedical Ethics and Regulation (33 papers), Intellectual Property and Patents (28 papers) and Ethics in Clinical Research (18 papers). Timo Minssen is often cited by papers focused on Biomedical Ethics and Regulation (33 papers), Intellectual Property and Patents (28 papers) and Ethics in Clinical Research (18 papers). Timo Minssen collaborates with scholars based in Denmark, United States and United Kingdom. Timo Minssen's co-authors include Sara Gerke, I. Glenn Cohen, Mateo Aboy, Effy Vayena, W. Nicholson Price, Ariel Dora Stern, Marcel Bogers, Henry Chesbrough, Theodoros Evgeniou and Marcelo Corrales Compagnucci and has published in prestigious journals such as Science, JAMA and Nature Biotechnology.

In The Last Decade

Timo Minssen

112 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timo Minssen Denmark 18 333 276 192 163 123 128 1.4k
Tung Manh Ho Vietnam 28 267 0.8× 97 0.4× 291 1.5× 267 1.6× 120 1.0× 111 2.2k
W. Nicholson Price United States 15 640 1.9× 384 1.4× 456 2.4× 120 0.7× 354 2.9× 50 2.1k
Saptarshi Purkayastha United States 20 287 0.9× 69 0.3× 185 1.0× 91 0.6× 209 1.7× 93 1.3k
Ariel Dora Stern United States 26 143 0.4× 348 1.3× 173 0.9× 479 2.9× 39 0.3× 82 2.0k
Jane Snowdon United States 14 359 1.1× 176 0.6× 269 1.4× 43 0.3× 249 2.0× 38 1.7k
Sara Gerke United States 23 975 2.9× 415 1.5× 423 2.2× 111 0.7× 363 3.0× 59 2.0k
Dasharathraj K Shetty India 14 341 1.0× 111 0.4× 182 0.9× 45 0.3× 222 1.8× 69 1.1k
Matthias Braun Germany 16 219 0.7× 177 0.6× 143 0.7× 37 0.2× 45 0.4× 91 1.2k
Jean‐Paul Fortin Canada 24 221 0.7× 686 2.5× 142 0.7× 153 0.9× 134 1.1× 71 1.9k
Blake Murdoch Canada 11 254 0.8× 266 1.0× 147 0.8× 63 0.4× 121 1.0× 33 893

Countries citing papers authored by Timo Minssen

Since Specialization
Citations

This map shows the geographic impact of Timo Minssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Minssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Minssen more than expected).

Fields of papers citing papers by Timo Minssen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Minssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Minssen. The network helps show where Timo Minssen may publish in the future.

Co-authorship network of co-authors of Timo Minssen

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Minssen. A scholar is included among the top collaborators of Timo Minssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Minssen. Timo Minssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Minssen, Timo, et al.. (2025). The future of AI regulation in drug development: a comparative analysis. Journal of Law and the Biosciences. 12(2). lsaf028–lsaf028.
2.
Compagnucci, Marcelo Corrales, et al.. (2024). The new EU–US data protection framework’s implications for healthcare. Journal of Law and the Biosciences. 11(2). lsae022–lsae022. 12 indexed citations
3.
Aboy, Mateo, Timo Minssen, & Effy Vayena. (2024). Navigating the EU AI Act: implications for regulated digital medical products. npj Digital Medicine. 7(1). 237–237. 43 indexed citations
4.
Liddell, Kathleen, Susan Rogers Van Katwyk, Steven J. Hoffman, et al.. (2024). Analyzing antimicrobial resistance as a series of collective action problems. SSRN Electronic Journal. 1 indexed citations
5.
Li, Phoebe, et al.. (2024). Core Legal Challenges for Medical 3D Printing in the EU. Healthcare. 12(11). 1114–1114. 9 indexed citations
6.
Liddicoat, John, et al.. (2023). Repositioning Generic Drugs: Empirical Findings and Policy Implications. SSRN Electronic Journal. 2 indexed citations
7.
Aboy, Mateo, et al.. (2023). Towards Responsible Quantum Technology. SSRN Electronic Journal. 10 indexed citations
8.
Li, Phoebe, et al.. (2023). Legal issues and underexplored data protection in medical 3D printing: A scoping review. Frontiers in Bioengineering and Biotechnology. 11. 1102780–1102780. 12 indexed citations
9.
10.
Slokenberga, Santa, et al.. (2023). Governing, Protecting, and Regulating the Future of Genome Editing. Directory of Open access Books (OAPEN Foundation). 2 indexed citations
11.
Zimmeren, Esther van, Timo Minssen, Walter Van Dyck, et al.. (2022). Compulsory licensing for expensive medicines. 1 indexed citations
12.
Matthews, Duncan & Timo Minssen. (2021). Debating IP waivers will fuel pandemic innovation. Research at the University of Copenhagen (University of Copenhagen).
13.
Minssen, Timo, et al.. (2020). Clinical trial data transparency and GDPR compliance: Implications for data sharing and open innovation. Science and Public Policy. 47(5). 616–626. 20 indexed citations
14.
Minssen, Timo, et al.. (2019). What lurks in the shadows of the openness hyperbole for biopharmaceuticals?. Drug Development Research. 80(3). 282–284. 4 indexed citations
15.
Minssen, Timo, et al.. (2019). Regulating germline editing in assisted reproductive technology: An EU cross‐disciplinary perspective. Bioethics. 34(1). 16–32. 10 indexed citations
16.
Holman, Christopher M., et al.. (2018). Patentability Standards for Follow-On Pharmaceutical Innovation. Biotechnology Law Report. 37(3). 131–161.
17.
Minssen, Timo & Jens Schovsbo. (2018). Big Data in the Health and Life Sciences: What Are the Challenges for European Competition Law and Where Can They Be Found?. SSRN Electronic Journal. 121–130. 2 indexed citations
18.
19.
Minssen, Timo & Robert M. Schwartz. (2011). US Patent Eligibility in the Wake of Bilski v Kappos : “Business as Usual” in an Age of New Technologies?. Biotechnology Law Report. 30(1). 3–56. 1 indexed citations
20.
Minssen, Timo. (2009). Meanwhile on the Other Side of the Pond: Why Biopharmaceutical Inventions that Were 'Obvious to Try' Still Might Be Non-Obvious – Part I. Lund University Publications (Lund University). 9(1). 60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tung Manh Ho Breakdown of academic impact, for papers by W. Nicholson Price Breakdown of academic impact, for papers by Saptarshi Purkayastha Breakdown of academic impact, for papers by Ariel Dora Stern Breakdown of academic impact, for papers by Jane Snowdon Breakdown of academic impact, for papers by Sara Gerke Breakdown of academic impact, for papers by Dasharathraj K Shetty Breakdown of academic impact, for papers by Matthias Braun Breakdown of academic impact, for papers by Jean‐Paul Fortin Breakdown of academic impact, for papers by Blake Murdoch
Rankless by CCL
2026